Certara, Inc.

CERT

US15687V1098

Software

Real-time Estimate Cboe BZX Other stock markets 02:22:49 2024-07-05 pm EDT			5-day change	1st Jan Change
14.1 ^USD	+1.91%		+2.17%	-19.56%

Jul. 01	Certara, Inc.(NasdaqGS:CERT) dropped from Russell Midcap Growth Index	CI
Jul. 01	Certara, Inc.(NasdaqGS:CERT) dropped from Russell 3000E Growth Index	CI

Brazilian Health Surveillance Agency ANVISA Adopts Certara Phoenix Software for Drug Regulatory Reviews

January 17, 2018 at 01:00 pm EST

Certara announced that the Brazilian National Health Surveillance Agency is now also employing Certaras Phoenix WinNonlin software for reviewing drug regulatory submissions.

Latest news about Certara, Inc.

Certara, Inc.(NasdaqGS:CERT) dropped from Russell Midcap Growth Index	Jun. 30	CI
Certara, Inc.(NasdaqGS:CERT) dropped from Russell 3000E Growth Index	Jun. 30	CI
Certara, Inc.(NasdaqGS:CERT) dropped from Russell 3000 Growth Index	Jun. 30	CI
Certara, Inc.(NasdaqGS:CERT) dropped from Russell 2500 Growth Index	Jun. 30	CI
Certara, Inc.(NasdaqGS:CERT) dropped from Russell Small Cap Comp Growth Index	Jun. 30	CI
Certara, Inc.(NasdaqGS:CERT) dropped from Russell 1000 Growth Index	Jun. 30	CI
Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating	Jun. 28	MT
Certara Launches Next Generation CoAuthor? Generative AI Regulatory Writing Software	Jun. 17	CI
Transcript : Certara, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11:30 AM	Jun. 05
Certara, Inc Appoints Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel	May. 21	CI
Transcript : Certara, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM	May. 14
Certara Q1 Adjusted Earnings Down, Revenue Increases	May. 08	MT
Certara, Inc. Reiterates Earnings Guidance for the Year 2024	May. 07	CI
Transcript : Certara, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Earnings Flash (CERT) CERTARA Posts Q1 EPS $0.10, vs. Street Est of $0.10	May. 07	MT
Earnings Flash (CERT) CERTARA Reports Q1 Revenue $96.7M, vs. Street Est of $93.6M	May. 07	MT
Certara, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Certara Launches Cloud Platform to Unify Scientific Software Solutions	Apr. 16	MT
Certara, Inc. Launches Cloud Platform to Further Unify Its End-To-End Scientific Software Platform	Apr. 16	CI
North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
Sector Update: Health Care Stocks Slipping Late Afternoon	Apr. 10	MT
Certara Poised to Benefit From Improving End Markets, KeyBanc Says	Apr. 10	MT
KeyBanc Upgrades Certara to Overweight From Sector Weight on Higher Conviction of Top-Line Trends, Sets $23 Price Target	Apr. 10	MT
North American Morning Briefing : Traders Await -2-	Apr. 10	DJ
Certara Shares Rise After JMP Securities Starts Coverage at Market Perform	Apr. 04	MT

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

Sector

Software

Calendar

2024-08-05 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Certara, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

13.84 USD

Average target price

19.5 USD

Spread / Average Target

+40.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
CERTARA, INC.	-19.56%	2.23B
MICROSOFT CORPORATION	+24.16%	3,425B
SYNOPSYS INC.	+20.42%	93B
CADENCE DESIGN SYSTEMS, INC.	+18.00%	86.49B
PALANTIR TECHNOLOGIES INC.	+56.90%	57.57B
DASSAULT SYSTÈMES SE	-19.11%	50.11B
THE TRADE DESK, INC.	+38.85%	48.65B
ATLASSIAN CORPORATION	-21.68%	47.44B
SEA LIMITED	+76.35%	41.06B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-5.50%	26.86B

Other Software

Certara, Inc.

Equities

CERT

US15687V1098

Software

Brazilian Health Surveillance Agency ANVISA Adopts Certara Phoenix Software for Drug Regulatory Reviews

Latest news about Certara, Inc.

Chart Certara, Inc.

Company Profile

Income Statement Evolution

Ratings for Certara, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Software